44 related articles for article (PubMed ID: 23121858)
1. Higher rates of allergies, autoimmune diseases and low-grade inflammation markers in treatment-resistant major depression.
Lauden A; Geishin A; Merzon E; Korobeinikov A; Green I; Golan-Cohen A; Vinker S; Manor I; Weizman A; Magen E
Brain Behav Immun Health; 2021 Oct; 16():100313. PubMed ID: 34589804
[TBL] [Abstract][Full Text] [Related]
2. Duality of Antidepressants and Neuroprotectants.
Tizabi Y
Neurotox Res; 2016 Jul; 30(1):1-13. PubMed ID: 26613895
[TBL] [Abstract][Full Text] [Related]
3. Comorbidity and healthcare utilization in patients with treatment resistant depression: A large-scale retrospective cohort analysis using electronic health records.
Adekkanattu P; Olfson M; Susser LC; Patra B; Vekaria V; Coombes BJ; Lepow L; Fennessy B; Charney A; Ryu E; Miller KD; Pan L; Yangchen T; Talati A; Wickramaratne P; Weissman M; Mann J; Biernacka JM; Pathak J
J Affect Disord; 2023 Mar; 324():102-113. PubMed ID: 36529406
[TBL] [Abstract][Full Text] [Related]
4. Healthcare resource utilization in patients with treatment-resistant depression-A Danish national registry study.
Jensen KJ; Gronemann FH; Ankarfeldt MZ; Jimenez-Solem E; Alulis S; Riise J; Bødker N; Osler M; Petersen J
PLoS One; 2022; 17(9):e0275299. PubMed ID: 36166443
[TBL] [Abstract][Full Text] [Related]
5. Clinical research challenges posed by difficult-to-treat depression.
Rush AJ; Sackeim HA; Conway CR; Bunker MT; Hollon SD; Demyttenaere K; Young AH; Aaronson ST; Dibué M; Thase ME; McAllister-Williams RH
Psychol Med; 2022 Feb; 52(3):419-432. PubMed ID: 34991768
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis.
Döme P; Kunovszki P; Takács P; Fehér L; Balázs T; Dede K; Mulhern-Haughey S; Barbreau S; Rihmer Z
PLoS One; 2021; 16(1):e0245510. PubMed ID: 33471854
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and improved outcomes in major depression: a review.
Kraus C; Kadriu B; Lanzenberger R; Zarate CA; Kasper S
Transl Psychiatry; 2019 Apr; 9(1):127. PubMed ID: 30944309
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in the treatment of refractory mood disorders: a case series.
Muneer A
Clin Psychopharmacol Neurosci; 2014 Aug; 12(2):157-9. PubMed ID: 25191507
[TBL] [Abstract][Full Text] [Related]
9. The lack of association between components of metabolic syndrome and treatment resistance in depression.
Sagud M; Mihaljevic-Peles A; Uzun S; Cusa BV; Kozumplik O; Kudlek-Mikulic S; Mustapic M; Barisic I; Muck-Seler D; Pivac N
Psychopharmacology (Berl); 2013 Nov; 230(1):15-21. PubMed ID: 23579429
[TBL] [Abstract][Full Text] [Related]
10. Treatment resistant depression and axis I co-morbidity.
Petersen T; Gordon JA; Kant A; Fava M; Rosenbaum JF; Nierenberg AA
Psychol Med; 2001 Oct; 31(7):1223-9. PubMed ID: 11681548
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants for major depressive disorder in patients with a co-morbid axis-III disorder: a meta-analysis of patient characteristics and placebo response rates in randomized controlled trials.
Iovieno N; Tedeschini E; Ameral VE; Rigatelli M; Papakostas GI
Int Clin Psychopharmacol; 2011 Mar; 26(2):69-74. PubMed ID: 20962663
[TBL] [Abstract][Full Text] [Related]
12. Identifying difficult-to-treat depression: differential diagnosis, subtypes, and comorbidities.
Gaynes BN
J Clin Psychiatry; 2009; 70 Suppl 6():10-5. PubMed ID: 19922739
[TBL] [Abstract][Full Text] [Related]
13. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.
Amital D; Fostick L; Silberman A; Calati R; Spindelegger C; Serretti A; Juven-Wetzler A; Souery D; Mendlewicz J; Montgomery S; Kasper S; Zohar J
Eur Neuropsychopharmacol; 2013 Aug; 23(8):895-901. PubMed ID: 23121858
[TBL] [Abstract][Full Text] [Related]
14. The economic impact of depression: resistance or severity?
Fostick L; Silberman A; Beckman M; Spivak B; Amital D
Eur Neuropsychopharmacol; 2010 Oct; 20(10):671-5. PubMed ID: 20624674
[TBL] [Abstract][Full Text] [Related]
15. Serious life events among resistant and non-resistant MDD patients.
Amital D; Fostick L; Silberman A; Beckman M; Spivak B
J Affect Disord; 2008 Oct; 110(3):260-4. PubMed ID: 18262654
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
